Home Cart 0 Sign in  
X

[ CAS No. 23100-12-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 23100-12-1
Chemical Structure| 23100-12-1
Chemical Structure| 23100-12-1
Structure of 23100-12-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 23100-12-1 ]

Related Doc. of [ 23100-12-1 ]

Alternatived Products of [ 23100-12-1 ]

Product Details of [ 23100-12-1 ]

CAS No. :23100-12-1 MDL No. :MFCD03095223
Formula : C6H4ClNO Boiling Point : -
Linear Structure Formula :- InChI Key :AFWWKZCPPRPDQK-UHFFFAOYSA-N
M.W : 141.56 Pubchem ID :2764053
Synonyms :

Calculated chemistry of [ 23100-12-1 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 34.63
TPSA : 29.96 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.29 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.26
Log Po/w (XLOGP3) : 1.23
Log Po/w (WLOGP) : 1.55
Log Po/w (MLOGP) : 0.4
Log Po/w (SILICOS-IT) : 2.16
Consensus Log Po/w : 1.32

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.92
Solubility : 1.7 mg/ml ; 0.012 mol/l
Class : Very soluble
Log S (Ali) : -1.46
Solubility : 4.95 mg/ml ; 0.0349 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.56
Solubility : 0.387 mg/ml ; 0.00274 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.28

Safety of [ 23100-12-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 23100-12-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 23100-12-1 ]
  • Downstream synthetic route of [ 23100-12-1 ]

[ 23100-12-1 ] Synthesis Path-Upstream   1~25

  • 1
  • [ 23100-12-1 ]
  • [ 100-55-0 ]
YieldReaction ConditionsOperation in experiment
88% With hydrogen; sodium acetate; palladium dichloride In methanol at 35℃; for 2 h; Typical procedures: 6-bromonicotinaldehyde (930 mg, 5.0 mmol), NaOAc (820 mg, 10.0 mmol), MeOH (30 mL), and PdCl2 (45 mg) were mixed in a glass bottle capped with a balloon filled with hydrogen. After stirred at 35 °C for 4 h, the mixture was filtered and washed with MeOH. The solvent was removed and the residue was dissolved in water, neutralized with solid NaHCO3, and extracted with ethyl acetate. The organic phase was dried over anhyd Na2SO4, and then filtered. The solvent was removed and the residue was subjected to chromatography to yield pyridin-3-ylmethanol (428 mg, 78percent).
Reference: [1] Tetrahedron Letters, 2012, vol. 53, # 29, p. 3798 - 3801
  • 2
  • [ 33252-28-7 ]
  • [ 3731-52-0 ]
  • [ 23100-12-1 ]
  • [ 97004-04-1 ]
Reference: [1] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[2] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[3] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[4] Bulletin of the Chemical Society of Japan, 2000, vol. 73, # 5, p. 1227 - 1231
  • 3
  • [ 105827-78-9 ]
  • [ 616-45-5 ]
  • [ 5326-23-8 ]
  • [ 6271-78-9 ]
  • [ 23100-12-1 ]
  • [ 463-04-7 ]
  • [ 625-74-1 ]
  • [ 120868-66-8 ]
Reference: [1] Chinese Journal of Chemistry, 2012, vol. 30, # 1, p. 127 - 132
  • 4
  • [ 21543-49-7 ]
  • [ 23100-12-1 ]
YieldReaction ConditionsOperation in experiment
96% With oxalyl dichloride; triethylamine In dimethyl sulfoxide at -78 - 20℃; for 2.5 h; According to a procedure of Lee et al. [22] oxalylchloride (3.81 g, 30.0 mmol, 3.0 eq) was dissolved in CH2Cl2 (35 mL) at -78C (dry ice/acetone). Then DMSO (46.9 g, 0.60 mol, 60.0 eq.)was added dropwise under stirring and the reaction mixture was stirred for additional 30 min at -78C. Then 2-chloro-5-(hydroxymethyl)pyridine (1.44 g, 10.0 mmol, 1.00 eq) was dissolved in CH2Cl2(10 mL) and added dropwise with a syringe to the cold reaction mixture. Afterwards, the reaction mixture was stirred for 40 min at -78C and NEt3 (91.9 g, 0.90 mol, 90.0 eq) was added to the reaction mixture at a rate of 2.0 mL/min. The reaction mixture was stirred for 1 h at -78C, followed by another 1.5 h stirring at r.t. The reaction mixture was then diluted with Et2O (60 mL) and the organic phase was washed successively withNaHCO3(sat., aq., 2 × 30 mL), KHSO4(1 M, aq., 60 mL) and NaHCO3(sat., aq., 30 mL). After phase separation the organic phase was dried over Na2SO4, the solid removed by filtration and the solvent was removed in vacuum. Further cleaning with liquid chromatography(LC) (SiO2, n-pentane/EtOAc/NEt3= 200/100/6) gave the desired product as yellowish solid (1.35 g, 96percent).
94% at 20℃; for 6 h; General procedure: To a mixture of alcohol in dry DMSO (10 volume) was added 1 equiv of polymer bromide and the reaction mixture was stirred at room temperature for a given period of time (Table 1). After the completion of the reaction, the reaction mixture was filtered and the polymer bed washed with DMSO. Combined DMSO layers were quenched with ice-water mixture and extracted with ether. The ether layer was given water wash, brine wash, dried over anhydrous sodium sulphate, and concentrated to get the pure carbonyl compounds. All the products were characterized by NMR and MS analysis.
87% With manganese(IV) oxide In chloroform at 60℃; To a solution of the alcohol from above (481 mg, 3.35 mmol) in CHCl3 (25 mL) was added MnO2 (85percent, 3.14 g, 30.7 mmol) and the suspension stirred at 60 0C overnight. The reaction was cooled, filtered through Celite.(R)., washing the cake with CH2Cl2 and MeOH and the resultant filtrate concentrated to afford the desired aldehyde (0.41 g, 87percent) as a yellow solid. To a solution of 6-chloro-3-pyridinecarboxaldehyde (210 mg, 1.48 mmol) and ρyrimidine-5-boronic acid (207 mg, 1.67 mmol) in THF/DME/2 M Na2CO3 (1:2:1, 4 mL) was added Pd(PPh3)4 (154 mg, 0.13 mmol) and the reaction stirred under argon at 90 0C overnight. Standard work-up and purification by column chromatography on silica gel (CH2Cl2ZMeOH, 95:5) afforded -pyrimidm-S-yl-pyridme-S-carbaldehyde (80 mg, 29percent) as a yellow solid. 1H NMR (CDCl3) δ 7.96 (d, IH, J= 8.1 Hz), 8.32 (dd, IH, J= 8.1, 1.5 Hz), 9.20 (d, IH, J = 1.5 Hz), 9.32 (s, IH), 9.42 (s, 2H), 10.18 (s, IH).
89 %Chromat. With 1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione In dichloromethane at 25℃; for 0.5 h; General procedure: DBDMH (1 mmol) was added to a mixture of 1b (1 mmol) and dichloromethane (20ml). The reaction was kept at room temperature. After the mixture was stirred for0.5h, the mixture was washed with water (330 ml),dried with anhydrous MgSO4,filtered, and vacuum evaporated. The residue was purified by column chromatography (silica gel: petroleum ether/ethyl acetate, 30:1) to afford the product as light yellowsolid (93percent yield).
15 g With pyridinium chlorochromate In dichloromethane at 0 - 20℃; for 2 h; To a solution of PCC (58 g, 0.27 mol) in DCM (1500 ml) was added the product of the proceeding step (26 g, 0.184mol) as a solution in DCM drop wise at 0°C. The mixture was then stirred for 2h at 20°C. It was filtered through diatomaceous earth and the filter contents were washed with DCM. The organic phase was concentrated to give the crude product, which was purified by column chromatography to give the product (15 g, yield: 60.1 percent). 1H NMR (400 MHz, CDCI3): δ 10.067 (s, 1 H), 8.874 (s, 1 H, J=3Hz), 8.158-8.138 (d, 1 H, J=8Hz), 7.534-7.513 (d, 1 H, J=8Hz)

Reference: [1] Chemical Communications, 1999, # 18, p. 1907 - 1908
[2] Organic Letters, 2005, vol. 7, # 14, p. 2965 - 2967
[3] Electrochimica Acta, 2014, vol. 140, p. 101 - 107
[4] Chemistry - A European Journal, 2016, vol. 22, # 15, p. 5319 - 5326
[5] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 10, p. 1253 - 1255
[6] Tetrahedron Letters, 2011, vol. 52, # 51, p. 6971 - 6973
[7] Chemical and Pharmaceutical Bulletin, 2000, vol. 48, # 5, p. 694 - 707
[8] Journal of Medicinal Chemistry, 2014, vol. 57, # 3, p. 1079 - 1089
[9] Journal of Organic Chemistry, 1993, vol. 58, # 21, p. 5600 - 5602
[10] Synthesis, 1998, # 9, p. 1335 - 1338
[11] Journal of Medicinal Chemistry, 2012, vol. 55, # 3, p. 1274 - 1286
[12] Patent: WO2007/22371, 2007, A2, . Location in patent: Page/Page column 72
[13] Organic Letters, 2001, vol. 3, # 19, p. 3009 - 3012
[14] Journal of Organic Chemistry, 1998, vol. 63, # 3, p. 760 - 768
[15] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 9, p. 1571 - 1574
[16] Journal of Physical Organic Chemistry, 2017, vol. 30, # 2,
[17] Synthesis, 1994, # 1, p. 87 - 92
[18] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 7, p. 2013 - 2016
[19] Synthetic Communications, 2014, vol. 44, # 8, p. 1155 - 1164
[20] Patent: WO2014/167084, 2014, A1, . Location in patent: Page/Page column 80
[21] Synthetic Communications, 2016, vol. 46, # 7, p. 636 - 644
  • 5
  • [ 2591-86-8 ]
  • [ 53939-30-3 ]
  • [ 23100-12-1 ]
YieldReaction ConditionsOperation in experiment
68%
Stage #1: With n-butyllithium In diethyl ether; hexane at -50 - -45℃; Inert atmosphere
Stage #2: at -70 - 20℃;
5-Bromo-2-chloropyridine (T-9) (15.0 g) and diethyl ether (450 ml) were put in a reaction vessel and cooled to -50 °C under an atmosphere of nitrogen. n-Butyllithium (1.57 M in n-hexane; 54.6 ml) was added dropwise in the temperature range of -50 °C to -45 °C, and the stirring was continued for another 90 minutes. After the reaction vessel had been cooled to -70 °C, formylpiperidine (9.70 g) was added dropwise in the temperature range of -70 °C to -65 °C, and the stirring was continued for another 60 minutes while the mixture was allowed to return to room temperature. The resulting reaction mixture was poured into ice-water (500 ml) and mixed with it. Diethyl ether (200 ml) was added to the solution to separate organic and aqueous phases, and extraction was carried out. The combined organic phase was washed with water and dried over anhydrous magnesium sulfate. The resulting solution was concentrated under reduced pressure and the residue was purified with a fractional operation by means of column chromatography (silica gel; toluene). The product was further purified by recrystallization from heptane. The solvent was distilled off and the product was dried, giving 2-chloro-5-formylpyridine (T-10) (7.01 g). The yield based on the compound (T-9) was 68percent.
Reference: [1] Patent: EP2351741, 2011, A1, . Location in patent: Page/Page column 53
[2] Patent: KR101512525, 2015, B1, . Location in patent: Paragraph 0133-0135
  • 6
  • [ 70258-18-3 ]
  • [ 23100-12-1 ]
YieldReaction ConditionsOperation in experiment
81% With sodium dihydrogenphosphate; potassium bromide In dimethyl sulfoxide; toluene at 90 - 100℃; Inert atmosphere Take 50g of raw material 2-chloro-5-chloromethyl pyridine,Soluble in 100g DMSO and 200g tolueneAdd 48g of sodium dihydrogen phosphate,3g of potassium bromide. Stirring,Nitrogen was bubbled under the liquid surface.Warm up to 90100°C reaction.After the reaction was completed, it was briefly distilled under reduced pressure and purified by distillation. The distillate was added with 50 g of water and 100 g of methyl tert-butyl ether (MTBE). The mixture was washed and separated, and the MTBE was recovered from the organic phase to obtain 2-chloro-5-aldehyde pyridine, which was weighed 35.6 g and the molar yield was about 81percent.
Reference: [1] Patent: CN107698497, 2018, A, . Location in patent: Paragraph 0072; 0073; 0074; 0077; 0080; 0083
  • 7
  • [ 33252-28-7 ]
  • [ 23100-12-1 ]
Reference: [1] Patent: US2002/77478, 2002, A1,
[2] Patent: US2002/128247, 2002, A1,
[3] Patent: US4317913, 1982, A,
[4] Patent: EP1138685, 2001, A2,
[5] Patent: WO2007/65669, 2007, A1, . Location in patent: Page/Page column 32
[6] Patent: EP1236723, 2002, A1, . Location in patent: Page 20
  • 8
  • [ 5326-23-8 ]
  • [ 23100-12-1 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 37, p. 7381 - 7389
[2] Journal of the Chemical Society, Chemical Communications, 1994, # 15, p. 1775 - 1776
[3] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 7, p. 2013 - 2016
[4] Organic Letters, 2001, vol. 3, # 19, p. 3009 - 3012
[5] Chemical and Pharmaceutical Bulletin, 2000, vol. 48, # 5, p. 694 - 707
[6] Synthesis, 1998, # 9, p. 1335 - 1338
[7] Journal of Organic Chemistry, 1998, vol. 63, # 3, p. 760 - 768
[8] Journal of Organic Chemistry, 1993, vol. 58, # 21, p. 5600 - 5602
[9] Patent: WO2014/167084, 2014, A1,
  • 9
  • [ 69045-79-0 ]
  • [ 68-12-2 ]
  • [ 23100-12-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 15, p. 3427 - 3430
[2] Patent: WO2005/9479, 2005, A1, . Location in patent: Page/Page column 41
  • 10
  • [ 68-12-2 ]
  • [ 23100-12-1 ]
Reference: [1] Patent: EP1748048, 2007, A1, . Location in patent: Page/Page column 41
  • 11
  • [ 33252-28-7 ]
  • [ 3731-52-0 ]
  • [ 23100-12-1 ]
  • [ 97004-04-1 ]
Reference: [1] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[2] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[3] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[4] Bulletin of the Chemical Society of Japan, 2000, vol. 73, # 5, p. 1227 - 1231
  • 12
  • [ 72637-18-4 ]
  • [ 23100-12-1 ]
Reference: [1] Patent: US5051513, 1991, A,
  • 13
  • [ 149281-42-5 ]
  • [ 23100-12-1 ]
Reference: [1] Patent: WO2005/60967, 2005, A1, . Location in patent: Page/Page column 21
  • 14
  • [ 73781-91-6 ]
  • [ 23100-12-1 ]
Reference: [1] Organic Letters, 2005, vol. 7, # 14, p. 2965 - 2967
[2] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 9, p. 1571 - 1574
[3] Journal of Medicinal Chemistry, 2014, vol. 57, # 3, p. 1079 - 1089
  • 15
  • [ 182924-36-3 ]
  • [ 23100-12-1 ]
Reference: [1] Synthetic Communications, 2010, vol. 40, # 8, p. 1106 - 1114
  • 16
  • [ 1603-41-4 ]
  • [ 23100-12-1 ]
Reference: [1] Synthesis, 1994, # 1, p. 87 - 92
  • 17
  • [ 3510-66-5 ]
  • [ 23100-12-1 ]
Reference: [1] Synthesis, 1994, # 1, p. 87 - 92
  • 18
  • [ 6311-35-9 ]
  • [ 23100-12-1 ]
Reference: [1] Synthesis, 1994, # 1, p. 87 - 92
  • 19
  • [ 58757-38-3 ]
  • [ 23100-12-1 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 10, p. 1253 - 1255
  • 20
  • [ 105827-78-9 ]
  • [ 616-45-5 ]
  • [ 5326-23-8 ]
  • [ 6271-78-9 ]
  • [ 23100-12-1 ]
  • [ 463-04-7 ]
  • [ 625-74-1 ]
  • [ 120868-66-8 ]
Reference: [1] Chinese Journal of Chemistry, 2012, vol. 30, # 1, p. 127 - 132
  • 21
  • [ 23100-12-1 ]
  • [ 101990-45-8 ]
Reference: [1] Patent: CN107698497, 2018, A, . Location in patent: Paragraph 0090; 0091
  • 22
  • [ 23100-12-1 ]
  • [ 90196-32-0 ]
Reference: [1] Patent: CN104529881, 2017, B,
  • 23
  • [ 23100-12-1 ]
  • [ 1121-55-7 ]
  • [ 536-78-7 ]
  • [ 90196-32-0 ]
Reference: [1] Patent: CN104529881, 2017, B,
  • 24
  • [ 23100-12-1 ]
  • [ 149806-06-4 ]
YieldReaction ConditionsOperation in experiment
28.7 g at 80 - 90℃; Autoclave Take 30g of 2-chloro-5-aldehyde pyridine in a Hastelloy autoclave,Add 40percent hydrobromic acid/acetic acid solution 240g,The reaction vessel was sealed and heated to 80-90°C with stirring.After the reaction is completed, the acetic acid is recovered by desolvation.The residue is added to 100g DCM,Adjust to neutral with saturated sodium bicarbonate.After separation and separation of the organic phase, 34.4 g of 2-bromo-5-aldehyde pyridine was obtained, with a yield of about 87percent.After desolvation, 100ml n-hexane was added to reflux for 30min. After cooling down to 0-10°C, it was filtered and dried to obtain 28.7g of a brown-yellow solid. The GC detection content was 99.2percent, and 2-chloro-5-aldehyde pyridine was 0.5percent in the product.
Reference: [1] Patent: CN107698497, 2018, A, . Location in patent: Paragraph 0086; 0087; 0088; 0089
  • 25
  • [ 33252-28-7 ]
  • [ 3731-52-0 ]
  • [ 23100-12-1 ]
  • [ 97004-04-1 ]
Reference: [1] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[2] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[3] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[4] Bulletin of the Chemical Society of Japan, 2000, vol. 73, # 5, p. 1227 - 1231
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 23100-12-1 ]

Chlorides

Chemical Structure| 55676-22-7

[ 55676-22-7 ]

3-Acetyl-6-chloropyridine

Similarity: 0.87

Chemical Structure| 1228957-10-5

[ 1228957-10-5 ]

2-Chloroisonicotinaldehyde hydrate(contain dehydrate aldehyde)

Similarity: 0.84

Chemical Structure| 101066-61-9

[ 101066-61-9 ]

2-Chloroisonicotinaldehyde

Similarity: 0.84

Chemical Structure| 6271-78-9

[ 6271-78-9 ]

6-Chloropyridine-3-carboxamide

Similarity: 0.84

Chemical Structure| 1256791-13-5

[ 1256791-13-5 ]

1-(6-Chloro-5-methylpyridin-3-yl)ethanone

Similarity: 0.82

Aldehydes

Chemical Structure| 1228957-10-5

[ 1228957-10-5 ]

2-Chloroisonicotinaldehyde hydrate(contain dehydrate aldehyde)

Similarity: 0.84

Chemical Structure| 101066-61-9

[ 101066-61-9 ]

2-Chloroisonicotinaldehyde

Similarity: 0.84

Chemical Structure| 55304-73-9

[ 55304-73-9 ]

2,6-Dichloro-3-formylpyridine

Similarity: 0.79

Chemical Structure| 36404-88-3

[ 36404-88-3 ]

2-Chloronicotinaldehyde

Similarity: 0.78

Chemical Structure| 790696-96-7

[ 790696-96-7 ]

2-chloro-3-methylisonicotinaldehyde

Similarity: 0.77

Related Parent Nucleus of
[ 23100-12-1 ]

Pyridines

Chemical Structure| 55676-22-7

[ 55676-22-7 ]

3-Acetyl-6-chloropyridine

Similarity: 0.87

Chemical Structure| 1228957-10-5

[ 1228957-10-5 ]

2-Chloroisonicotinaldehyde hydrate(contain dehydrate aldehyde)

Similarity: 0.84

Chemical Structure| 101066-61-9

[ 101066-61-9 ]

2-Chloroisonicotinaldehyde

Similarity: 0.84

Chemical Structure| 6271-78-9

[ 6271-78-9 ]

6-Chloropyridine-3-carboxamide

Similarity: 0.84

Chemical Structure| 1256791-13-5

[ 1256791-13-5 ]

1-(6-Chloro-5-methylpyridin-3-yl)ethanone

Similarity: 0.82